RG
EW icon

Renaissance Group’s Edwards Lifesciences EW Stock Holding History

Renaissance Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-157,944
Closed -$4.16M – 280
2015
Q4 		$4.16M Sell
157,944
-1,323,522
-89% -$34.4M 0.16% 112
2015
Q3 		$35.1M Sell
1,481,466
-13,392
-0.9% -$323K 1.4% 9
2015
Q2 		$35.5M Sell
1,494,858
-23,298
-2% -$526K 1.35% 12
2015
Q1 		$36M Sell
1,518,156
-70,104
-4% -$1.57M 1.36% 15
2014
Q4 		$33.7M Buy
+1,588,260
New +$31.9M 1.31% 24

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Group's EW Position: Q1 2016 in Review

Renaissance Group sold out of Edwards Lifesciences (EW) in Q1 2016, closing a stake of 157,944 shares — an estimated $4.16M sold.

Renaissance Group first reported a position in EW in Q4 2014 and held it in 5 quarters. The position peaked at $36M in Q1 2015. 659 funds tracked by Wall St. Rank hold EW as of Q1 2016.

  • Renaissance Group reported no remaining Edwards Lifesciences position as of Q1 2016 after selling out during the quarter.
  • Renaissance Group sold 157,944 Edwards Lifesciences shares in Q1 2016, an estimated $4.16M.
  • Renaissance Group first reported a position in Edwards Lifesciences in Q4 2014 and held it in 5 quarters.
  • Renaissance Group's Edwards Lifesciences position peaked at $36M in Q1 2015.
  • 659 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2016.

Based on Renaissance Group's 13F filing for Q1 2016, filed 3 May 2016.